Concomitant KRAS and BRAF mutations in colorectal cancer

被引：35

作者：

Midthun, Lauren ^{[1
]}

Shaheen, Shagufta ^{[2
]}

Deisch, Jeremy ^{[3
]}

Senthil, Maheswari ^{[4
]}

Tsai, James ^{[5
]}

Hsueh, Chung-Tsen ^{[5
]}

机构：

[1] Loma Linda Univ, Dept Internal Med, Loma Linda, CA 92354 USA

[2] Stanford Med Ctr, Div Oncol, Stanford, CA USA

[3] Loma Linda Univ, Dept Pathol & Human Anat, Loma Linda, CA 92354 USA

[4] Loma Linda Univ, Dept Surg, Loma Linda, CA 92354 USA

[5] Loma Linda Univ, Div Med Oncol & Hematol, Dept Internal Med, 11175 Campus St,CSP 11015, Loma Linda, CA 92354 USA

来源：

JOURNAL OF GASTROINTESTINAL ONCOLOGY | 2019年 / 10卷 / 03期

关键词：

BRAF; KRAS; colorectal cancer (CRC); SURVIVAL;

D O I：

10.21037/jgo.2019.01.10

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BRAF and KRAS are two key oncogenes in the RAS/RAF/MEK/MAP- kinase signaling pathway. While previously considered mutually exclusive, concomitant mutations in both KRAS and BRAF genes have been identified in colorectal cancer (CRC). The clinical outcome of these patients remains undetermined. We present the clinical course of two patients with CRC harboring mutations at codon 12 of KRAS and BRAF non-V600E mutations. More research is needed to determine the clinical- pathological effect of these simultaneous mutations of KRAS and BRAF in CRC on disease course and treatment

引用

页码：577 / 581

页数：5

共 50 条

[21] Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer
Ryota Nakanishi
Jun Harada
Munkhbold Tuul
Yan Zhao
Koji Ando
Hiroshi Saeki
Eiji Oki
Takefumi Ohga
Hiroyuki Kitao
Yoshihiro Kakeji
Yoshihiko Maehara
International Journal of Clinical Oncology, 2013, 18 : 1042 - 1048
[22] Impact of KRAS and BRAF Gene Mutations on Targeted Therapies in Colorectal Cancer
Bass, Adam
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (19) : 2728 - 2729
[23] Prognostic value of KRAS and BRAF mutations in curatively resected colorectal cancer
Shigenori Kadowaki
Miho Kakuta
Shuhei Takahashi
Akemi Takahashi
Yoshiko Arai
Yoji Nishimura
Toshimasa Yatsuoka
Akira Ooki
Kensei Yamaguchi
Keitaro Matsuo
Kei Muro
Kiwamu Akagi
World Journal of Gastroenterology, 2015, 21 (04) : 1275 - 1283
[24] KRAS and BRAF mutations in colorectal cancer patients in northwest of Iran.
Dolatkhah, Roya
Dastgiri, Saeed
Somi, Mohammad Hossein
Bonyadi, Morteza Jabbarpour
Kermani, Iraj Asvadi
Farassati, Faris
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[25] BRAF and KRAS mutations in stomach cancer
Lee, SH
Lee, JW
Soung, YH
Kim, HS
Park, WS
Kim, SY
Lee, JH
Park, JY
Cho, YG
Kim, CJ
Nam, SW
Kim, SH
Lee, JY
Yoo, NJ
ONCOGENE, 2003, 22 (44) : 6942 - 6945
[26] BRAF and KRAS mutations in stomach cancer
Sug Hyung Lee
Jong Woo Lee
Young Hwa Soung
Hong Sug Kim
Won Sang Park
Su Young Kim
Jong Heun Lee
Jik Young Park
Yong Gu Cho
Chang Jae Kim
Suk Woo Nam
Sang Ho Kim
Jung Young Lee
Nam Jin Yoo
Oncogene, 2003, 22 : 6942 - 6945
[27] KRAS and BRAF mutations in sinonasal cancer
Lopez, Fernando
Garcia Inclan, Cristina
Perez-Escuredo, Jhudit
Alvarez Marcos, Cesar
Scola, Bartolome
Suarez, Carlos
Luis Llorente, Jose
Hermsen, Mario A.
ORAL ONCOLOGY, 2012, 48 (08) : 692 - 697
[28] Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
Gokmen, Ivo
Tastekin, Ebru
Demir, Nazan
Ozcan, Erkan
Akgul, Fahri
Hacioglu, Muhammed Bekir
Erdogan, Bulent
Topaloglu, Sernaz
Cicin, Irfan
CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (10) : 7803 - 7812
[29] Distribution of some activating KRAS and BRAF mutations in Slovene patients with colorectal cancer
Alenka Ličar
Petra Cerkovnik
Srdjan Novaković
Medical Oncology, 2011, 28 : 1048 - 1053
[30] BRAF and KRAS mutations in metastatic colorectal cancer: future perspectives for personalized therapy
Li, Zi-Nan
Zhao, Lin
Yu, Li-Feng
Wei, Min-Jie
GASTROENTEROLOGY REPORT, 2020, 8 (03): : 192 - 205

← 1 2 3 4 5 →